During the past decade, Noven Pharmaceuticals, Inc. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Noven Pharmaceuticals, Inc." are "Osteoarthritis Pain of the Knee" (1 trials), "Osteoarthritis of the Knee" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Noven Pharmaceuticals, Inc." in a lesser frequency.

Most popular intervention types in "Noven Pharmaceuticals, Inc." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo patch" (2 trials), "Diclofenac Sodium Active Topical Patch 1" (1 trials), "Diclofenac Sodium Active Topical Patch 2" (1 trials), "Diclofenac sodium active topical patch" (1 trials) and "High Dose Asenapine maleate transdermal patch" (1 trials). Other intervention names were less common.

The vast majority of trials in "Noven Pharmaceuticals, Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Noven Pharmaceuticals, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Noven Pharmaceuticals, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Noven Pharmaceuticals, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".